Will SARS-COV-2 infection accelerate the incidence of Alzheimer's disease in Down syndrome population?

Barisic, Anita; Vranekovic, Jadranka

Barisic, Anita; Vranekovic, Jadranka.

Barisic A; Faculty of Medicine, Department of Medical Biology and Genetics, University of Rijeka, B. Branchetta 20, 51000, Rijeka, Croatia. anita.barisic@uniri.hr.
Vranekovic J; Faculty of Medicine, Department of Medical Biology and Genetics, University of Rijeka, B. Branchetta 20, 51000, Rijeka, Croatia.

Aging Clin Exp Res ; 34(11): 2919-2920, 2022 Nov.

Article in English | MEDLINE | ID: covidwho-2075754

Subject(s)

Alzheimer Disease; COVID-19; Down Syndrome; Humans; Alzheimer Disease/epidemiology; Alzheimer Disease/etiology; Down Syndrome/complications; Down Syndrome/epidemiology; COVID-19/epidemiology; Incidence; SARS-CoV-2

Keywords

Alzheimer's disease; Dementia; Infection hypothesis; SARS-CoV-2; Trisomy 21

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Down Syndrome / Alzheimer Disease / COVID-19 Type of study: Observational study Topics: Long Covid Limits: Humans Language: English Journal: Aging Clin Exp Res Journal subject: Geriatrics Year: 2022 Document Type: Article Affiliation country: S40520-022-02280-z

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google